GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocugen Inc (FRA:2H51) » Definitions » Shiller PE Ratio

Ocugen (FRA:2H51) Shiller PE Ratio : (As of Apr. 26, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Ocugen Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Ocugen Shiller PE Ratio Historical Data

The historical data trend for Ocugen's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocugen Shiller PE Ratio Chart

Ocugen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ocugen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Ocugen's Shiller PE Ratio

For the Biotechnology subindustry, Ocugen's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocugen's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocugen's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Ocugen's Shiller PE Ratio falls into.


;
;

Ocugen Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Ocugen's E10 for the quarter that ended in Dec. 2024 is calculated as:

For example, Ocugen's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.048/133.1571*133.1571
=-0.048

Current CPI (Dec. 2024) = 133.1571.

Ocugen Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201503 -33.263 99.621 -44.461
201506 -31.006 100.684 -41.006
201509 -32.610 100.392 -43.253
201512 -34.700 99.792 -46.302
201603 -32.327 100.470 -42.844
201606 -32.573 101.688 -42.653
201609 -37.421 101.861 -48.918
201612 -35.834 101.863 -46.843
201703 -15.147 102.862 -19.608
201706 -13.350 103.349 -17.200
201709 -11.578 104.136 -14.805
201712 -13.182 104.011 -16.876
201803 -25.303 105.290 -32.000
201806 -6.677 106.317 -8.363
201809 -12.341 106.507 -15.429
201812 -7.603 105.998 -9.551
201903 -6.372 107.251 -7.911
201906 -1.593 108.070 -1.963
201909 -3.223 108.329 -3.962
201912 0.212 108.420 0.260
202003 -0.063 108.902 -0.077
202006 -0.169 108.767 -0.207
202009 -0.059 109.815 -0.072
202012 -0.017 109.897 -0.021
202103 -0.034 111.754 -0.041
202106 -0.108 114.631 -0.125
202109 -0.043 115.734 -0.049
202112 -0.062 117.630 -0.070
202203 -0.082 121.301 -0.090
202206 -0.085 125.017 -0.091
202209 -0.101 125.227 -0.107
202212 -0.094 125.222 -0.100
202303 -0.075 127.348 -0.078
202306 -0.092 128.729 -0.095
202309 -0.047 129.860 -0.048
202312 -0.037 129.419 -0.038
202403 -0.046 131.776 -0.046
202406 -0.037 132.554 -0.037
202409 -0.045 133.029 -0.045
202412 -0.048 133.157 -0.048

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Ocugen  (FRA:2H51) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Ocugen Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Ocugen's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocugen Business Description

Traded in Other Exchanges
Address
11 Great Valley Parkway, Malvern, PA, USA, 19355
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Ocugen Headlines

No Headlines